Login to Your Account



Other news to note


Thursday, December 12, 2013

Receptos Inc., of San Diego, said that Ono Pharmaceuticals Co. Ltd., of Osaka, Japan. has elected to amend and expand their existing collaboration agreement to include transfer to Ono of the Receptos G-protein-coupled receptor (GPCR) technology platform, a high resolution protein crystal structure determination technology, which enables rational drug design for the GPCR therapeutic target class.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription